Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1852 3
1853 2
1854 1
1856 3
1857 1
1859 2
1860 1
1861 5
1862 5
1863 3
1864 3
1865 5
1867 1
1868 2
1869 1
1870 1
1874 3
1886 1
1908 1
1919 1
1921 1
1926 2
1927 2
1934 1
1936 1
1943 1
1945 1
1946 7
1947 8
1948 7
1949 8
1950 6
1951 6
1952 6
1953 3
1954 5
1955 5
1956 5
1957 14
1958 9
1959 4
1960 11
1961 9
1962 25
1963 10
1964 17
1965 20
1966 18
1967 24
1968 24
1969 20
1970 24
1971 27
1972 39
1973 37
1974 38
1975 44
1976 51
1977 57
1978 69
1979 63
1980 36
1981 77
1982 54
1983 64
1984 79
1985 91
1986 95
1987 126
1988 126
1989 155
1990 169
1991 201
1992 185
1993 203
1994 247
1995 280
1996 296
1997 317
1998 371
1999 454
2000 554
2001 666
2002 751
2003 932
2004 1118
2005 1369
2006 1560
2007 1857
2008 2150
2009 2344
2010 2705
2011 3058
2012 3538
2013 3727
2014 3995
2015 4263
2016 4159
2017 4342
2018 4374
2019 4565
2020 5269
2021 5633
2022 3988
2023 7
Text availability
Article attribute
Article type
Publication date

Search Results

63,693 results
Results by year
Filters applied: . Clear all
Page 1
Distinct transcriptome architectures underlying lupus establishment and exacerbation.
Nakano M, Ota M, Takeshima Y, Iwasaki Y, Hatano H, Nagafuchi Y, Itamiya T, Maeda J, Yoshida R, Yamada S, Nishiwaki A, Takahashi H, Takahashi H, Akutsu Y, Kusuda T, Suetsugu H, Liu L, Kim K, Yin X, Bang SY, Cui Y, Lee HS, Shoda H, Zhang X, Bae SC, Terao C, Yamamoto K, Okamura T, Ishigaki K, Fujio K. Nakano M, et al. Among authors: lee hs. Cell. 2022 Sep 1;185(18):3375-3389.e21. doi: 10.1016/j.cell.2022.07.021. Epub 2022 Aug 22. Cell. 2022. PMID: 35998627
Retraction: The Reversible Fourth-Generation EGFR Tyrosine Kinase Inhibitor OBX02-011 Overcomes C797S-Mediated Resistance in Lung Cancer.
Choi YJ, Kim DS, Sung YH, Kim DH, Im K, Lee H, Lee CW, Cho J, Min J, Woo DC, Kim SE, Lee S, Kong YJ, Ryu HC, Kim JS, Rengasamy R, Ji W, Choi CM, Lee JC, Rho JK. Choi YJ, et al. Among authors: lee h. Cancer Res. 2022 Aug 26:OF1. doi: 10.1158/0008-5472.CAN-22-2507. Online ahead of print. Cancer Res. 2022. PMID: 36018295 No abstract available.
Ferroptosis execution: Is it all about ACSL4?
Lee H, Gan B. Lee H, et al. Cell Chem Biol. 2022 Sep 15;29(9):1363-1365. doi: 10.1016/j.chembiol.2022.08.002. Cell Chem Biol. 2022. PMID: 36113403
Hospital variation in extremely preterm birth.
Goldstein GP, Kan P, Phibbs CS, Main E, Shaw GM, Lee HC. Goldstein GP, et al. Among authors: lee hc. J Perinatol. 2022 Sep 14. doi: 10.1038/s41372-022-01505-3. Online ahead of print. J Perinatol. 2022. PMID: 36104499
Gut Microbiota and Coronary Plaque Characteristics.
Nakajima A, Mitomo S, Yuki H, Araki M, Seegers LM, McNulty I, Lee H, Kuter D, Ishibashi M, Kobayashi K, Dijkstra J, Onishi H, Yabushita H, Matsuoka S, Kawamoto H, Watanabe Y, Tanaka K, Chou S, Naganuma T, Okutsu M, Tahara S, Kurita N, Nakamura S, Das S, Nakamura S, Jang IK. Nakajima A, et al. Among authors: lee h. J Am Heart Assoc. 2022 Sep 6;11(17):e026036. doi: 10.1161/JAHA.122.026036. Epub 2022 Aug 24. J Am Heart Assoc. 2022. PMID: 36000423 Free PMC article.
A Double-Edged Sword: The Two Faces of PARylation.
Kang M, Park S, Park SH, Lee HG, Park JH. Kang M, et al. Among authors: lee hg. Int J Mol Sci. 2022 Aug 29;23(17):9826. doi: 10.3390/ijms23179826. Int J Mol Sci. 2022. PMID: 36077221 Free PMC article. Review.
A limb bud morphogen bites the dust.
Lee H, Vokes SA. Lee H, et al. Dev Cell. 2022 Sep 12;57(17):2041-2042. doi: 10.1016/j.devcel.2022.08.007. Dev Cell. 2022. PMID: 36099905
Metastasis of Renal Cell Carcinoma to the Mandible.
Jung SY, Maeng JY, Lee H, Han JJ, Kim SM, Myoung H. Jung SY, et al. Among authors: lee h. J Craniofac Surg. 2022 Aug 29. doi: 10.1097/SCS.0000000000008985. Online ahead of print. J Craniofac Surg. 2022. PMID: 36036497
63,693 results
You have reached the last available page of results. Please see the User Guide for more information.